All-in-One procedure: simultaneous percutaneous treatment of aortic and mitral valve disease in inoperable patient.
Authors: Červinka P, Cihlář F, Vojtíšek P, Červinková M
Abstract
PMID: 30468362 [PubMed - as supplied by publisher] (Source: Minerva Cardioangiologica)
Source: Minerva Cardioangiologica - November 25, 2018 Category: Cardiology Tags: Minerva Cardioangiol Source Type: research
Efficacy of Pycnogenol ® supplementation in remission phases of Sjögren syndrome.
CONCLUSIONS: Pycnogenol® supplementation in patients with SS in a remission phase may be effective to control inflammation and reduce symptoms.
PMID: 30328688 [PubMed - in process] (Source: Minerva Cardioangiologica)
Source: Minerva Cardioangiologica - October 19, 2018 Category: Cardiology Tags: Minerva Cardioangiol Source Type: research
Effects of dronedarone on all-cause mortality and on cardiovascular events in patients treated for atrial fibrillation. A meta analysis of RCTs.
CONCLUSIONS: In our meta-analysis, dronedarone did not provide any significant benefit with regard to all-cause mortality and major cardiovascular events, as well as regarding the risk of worsening heart failure. Sensitivity analyses then showed that the exclusion of a study ,namely ATHENA study, caused a shift in the overall odds ratio, so as to convert the dronedarone use to the ominous role of predictor of higher mortality, worse cardiovascular morbidity and increased risk of worsening heart failure. Thus, dronedarone should be used with caution as second- line medication and exclusively for the secondary prevention of ...
Source: Minerva Cardioangiologica - September 29, 2018 Category: Cardiology Tags: Minerva Cardioangiol Source Type: research
Comparative analysis of cardiac cycle length during exercise in healthy people and cardiac patients.
Authors: Galindo-Canales M, Rojo-González JJ, Barriopedro MI, Ramos-Álvarez JJ, Calderón-Montero FJ
PMID: 30260142 [PubMed - as supplied by publisher] (Source: Minerva Cardioangiologica)
Source: Minerva Cardioangiologica - September 29, 2018 Category: Cardiology Tags: Minerva Cardioangiol Source Type: research
Electrocardiographic conduction and repolarization markers associated with sudden cardiac death: moving along the ECG waveform.
Authors: Reynard JT, Oshodi OM, Lai J, Lai R, Bazoukis G, Fragakis N, Letsas KP, Korantzopoulos P, Liu FZ, Liu T, Xia Y, Tse G, Li KH
Abstract
The QT interval along with its heart rate corrected form (QTc) are well- established ECG markers that have been found to be associated with malignant ventricular arrhythmogenesis. However, extensive pre-clinical and clinical investigations over the years have allowed for novel clinical ECG markers to be generated as predictors of arrhythmogenesis and sudden cardiac death. Repolarization markers include the older QTc, QT dispersion and newer Tpeak - Tend intervals, (...
Source: Minerva Cardioangiologica - September 29, 2018 Category: Cardiology Tags: Minerva Cardioangiol Source Type: research
Transcatheter aortic valve replacement in low risk patients.
Authors: Junquera L, Ferreira-Neto A, Guimaraes L, Asmarats L, Del Val D, Wintzer-Wehekind J, Muntané-Carol G, Freitas-Ferraz A, Rodés-Cabau J
Abstract
Transcatheter aortic valve replacement (TAVR) is a relatively new technology that has grown exponentially over the past decade. Although it was initially restricted to elderly patients at very high or prohibitive surgical risk, it is currently being evaluated as a treatment option in younger and lower risk patients. The increasing experience of the Heart Teams, along with the continued refinement of transcatheter valve technology has resulted in TAVR achi...
Source: Minerva Cardioangiologica - September 29, 2018 Category: Cardiology Tags: Minerva Cardioangiol Source Type: research
Cell therapy and left ventricular restoration for ischemic cardiomyopathy: long-term results of a perspective, randomized study.
CONCLUSIONS: Patients affected by ischemic cardiomyopathy have a favourable outcome after SVR.A higher reduction of LVEDV and LVESV assessed by CT-Scan evaluation in patients receiving cell therapy, when compared to control group, encourages the evolution and refinement of myocardial regenerative therapy added to SVR.
PMID: 30260145 [PubMed - as supplied by publisher] (Source: Minerva Cardioangiologica)
Source: Minerva Cardioangiologica - September 29, 2018 Category: Cardiology Tags: Minerva Cardioangiol Source Type: research
A glimpse into upcoming TAVI era: new is coming.
Authors: Kleczynski P
PMID: 30260146 [PubMed - as supplied by publisher] (Source: Minerva Cardioangiologica)
Source: Minerva Cardioangiologica - September 29, 2018 Category: Cardiology Tags: Minerva Cardioangiol Source Type: research
Deferred stenting for acute myocardial infarction of late admission.
Authors: Chen H, Zhu J, Zhuang Y
PMID: 30226029 [PubMed - as supplied by publisher] (Source: Minerva Cardioangiologica)
Source: Minerva Cardioangiologica - September 19, 2018 Category: Cardiology Tags: Minerva Cardioangiol Source Type: research
A novel approach to quantification of aortic valve calcifications in patients undergoing transcatheter aortic valve implantation.
CONCLUSIONS: Multiplane AVC quantitative evaluation provided details on total calcium amount, pattern and distribution in aortic valve. Established AVC parameters allowed better visualization of an operating area and prediction of PVL after TAVI.
PMID: 30226030 [PubMed - as supplied by publisher] (Source: Minerva Cardioangiologica)
Source: Minerva Cardioangiologica - September 19, 2018 Category: Cardiology Tags: Minerva Cardioangiol Source Type: research
Degeneration of prosthesis after transcatheter aortic valve implantation.
This article review will go through the current evidence of TAV durability, describing the types of failure and strategies of treatment.
PMID: 30226031 [PubMed - as supplied by publisher] (Source: Minerva Cardioangiologica)
Source: Minerva Cardioangiologica - September 19, 2018 Category: Cardiology Tags: Minerva Cardioangiol Source Type: research
Interaction study between antiplatelet agents, anticoagulants, diabetic therapy and a novel delivery form of quercetin.
CONCLUSIONS: Quercetin Phytosome® does not alter the antiplatelet activity of the most common antiplatelet agents, has no impact on the INR values in stable patients treated with warfarin or dabigatran, and does not influence the metabolic control of diabetic patient treated with metformin.
PMID: 30226032 [PubMed - as supplied by publisher] (Source: Minerva Cardioangiologica)
Source: Minerva Cardioangiologica - September 19, 2018 Category: Cardiology Tags: Minerva Cardioangiol Source Type: research
Prospective registry on cerebral oximetry-guided transcarotid TAVI in patients with moderate-high risk aortic stenosis.
CONCLUSIONS: The pilot registry showed the safety of transcarotid approach in patients with the anatomy precluding the transfemoral approach.
PMID: 30226033 [PubMed - as supplied by publisher] (Source: Minerva Cardioangiologica)
Source: Minerva Cardioangiologica - September 19, 2018 Category: Cardiology Tags: Minerva Cardioangiol Source Type: research
Could mechanical thrombectomy replace thrombolysis in the treatment of acute and subacute limb ischemia?
Authors: Stanek F, Ouhrabkova R, Prochazka D
Abstract
Acute limb ischemia is a vascular emergency defined as a sudden decrease in limb perfusion associated with a risk of loss of viability of the affected extremity. Surgical treatment (Fogarty thromboembolectomy) is indicated only in suprainguinal occlusions. Other cases of acute and subacute limb ischemia should be managed percutaneously. Catheter-based treatment involves local thrombolysis and percutaneous mechanical thrombectomy (PMT). There are several devices in use for PMT; of them, the Rotarex system appears to be the most useful. There are no rando...
Source: Minerva Cardioangiologica - September 1, 2018 Category: Cardiology Tags: Minerva Cardioangiol Source Type: research
Neuroprotective measures throughout the TAVI pathway.
Authors: Shiyoich A, Kornowski R
Abstract
Aortic stenosis (AS) is the most common clinical valvular heart disorder that warrants active treatment. Symptomatic and severe AS is associated with increased morbidity and mortality if left untouched. Transcatheter aortic valve implantation (TAVI) is an innovative therapeutic modality approved initially for patients with prohibitive surgical risk and subsequently became a mainstream practice and the preferred treatment modality for many patients with severe AS at high and moderate surgical risk. Consistently global TAVI volumes have increased and indications cont...
Source: Minerva Cardioangiologica - July 18, 2018 Category: Cardiology Tags: Minerva Cardioangiol Source Type: research
